Our services
M&A Advisory for Diagnostics, Manufacturing & Healthcare ServicesM&A Projects
$ in transactions
PharmaVentures provides strategic M&A advisory grounded in deep sector expertise and real-world experience. Our work spans three critical areas of healthcare and life sciences—each supported by specialist teams who combine technical insight with commercial acumen to drive value and execution.
Diagnostics & Life Sciences
PharmaVentures combines scientific, clinical and commercial expertise to deliver strategic advisory in Diagnostics & Life Sciences. We leverage our network of industry leaders, acquirers, and investors to connect clients with the right strategic and financial partners, driving optimal deal outcomes and long-term value creation.
Unlike generalist advisors, our team, comprising experienced scientists, medical doctors, and industry veterans, offers expert guidance in high-growth areas such as precision medicine, biomarkers, and next-gen diagnostics, identifying strategic partners others overlook.
Dedicated Advisor
Adrian Dawkes
Head of M&A
adrian@pharmaventures.com
Dedicated Advisor
Andreas Katsiamides
Diagnostics M&A Lead
andreas@pharmaventures.com
Pharma Manufacturing & Site Divestments
In Pharma Manufacturing & Site Divestments, PharmaVentures leverages its operational know-how and technical acumen to advise on facility optimisation, M&A, and strategic repositioning. Our track record of advising on over 40 manufacturing sites and transactions with a cumulative value exceeding $3 billion positions us to effectively execute even the most complex of deals.
Our team includes professionals with hands-on experience in pharmaceutical production, process engineering, and GMP compliance, ensuring that transactions are grounded in real-world feasibility. Whether divesting legacy sites, restructuring manufacturing networks, or negotiating partnerships, we provide data-driven insights that maximise value while mitigating risk. We understand that manufacturing decisions are not just financial—they shape supply chain resilience, regulatory flexibility, and long-term competitive advantage. Our advisory extends beyond transactions, helping clients future-proof their operations through scenario planning, capacity rationalisation, and tech transfer strategies.
Dedicated Advisor
Adrian Dawkes
Head of M&A
adrian@pharmaventures.com
Dedicated Advisor
Ross Jenkins
Pharma Services M&A Lead
ross@pharmaventures.com
Healthcare Services
PharmaVentures brings a distinct blend of medical, scientific, and strategic expertise to its Healthcare Services advisory, offering clients a nuanced perspective that bridges pharma innovation with patient care. At the core of this approach is a team that includes clinicians and healthcare strategists, ensuring that every recommendation is grounded in both clinical practicality and commercial viability. As healthcare systems embrace AI, telehealth, and remote monitoring, we evaluate emerging technologies, integrating digital tools into traditional care pathways, and addressing regulatory and reimbursement hurdles.
PharmaVentures ensures that its clients are not only keeping pace with innovation but are also positioned to lead in the evolving digital health landscape. Ultimately, PharmaVentures’ Healthcare Services advisory is about creating synergy between innovation and implementation.
Dedicated Advisor
Adrian Dawkes
Head of M&A
adrian@pharmaventures.com
Dedicated Advisor
Gurdas Singh
Healthcare Services M&A Lead
gurdas@pharmaventures.com
All FCA-regulated activities are delivered through PharmaVentures Capital Limited, which is authorised and regulated by the Financial Conduct Authority (741356). PharmaVentures Capital Limited is a wholly owned subsidiary of Pharma Ventures Ltd. Past performance is not a guarantee of future performance. Information contained herein is for illustrative purposes only and should not be relied upon.